Global Unresectable Hepatocellular Carcinoma Market
Unresectable Hepatocellular Carcinoma: Global Market Forecast at $2.64 Billion by 2028, Dominated by Pfizer, Johnson & Johnson, Roche, Merck & Co, and Bayer
07 mai 2024 12h33 HE | Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Unresectable Hepatocellular Carcinoma Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global unresectable...
22157.jpg
Metastatic Liver Cancer Pipeline Insight 2024, Featuring Key Players Oncorus, Sirnaomics, Codiak BioSciences, RemeGen, Amarin, Medivir, AstraZeneca, Amal Therapeutics and Boehringer Ingelheim
15 avr. 2024 07h20 HE | Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Liver Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides...
22157.jpg
Global Liver Cancer Drug Market to Reach USD 7.83 Billion by 2030: Innovative treatments like oncolytic viruses and RNA interference (RNAi) have gained market traction
10 avr. 2024 04h04 HE | Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Liver Cancer Drug Market Size, Share & Trends Analysis Report By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy), By Region, And...
22157.jpg
Doxorubicin Global Strategic Research Report 2024: Market to Reach $1.7 Billion by 2030 from $1.1 Billion in 2023, Driven by Rise in Cancer Incidence and Innovations in Cancer Drug Delivery
05 avr. 2024 09h07 HE | Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Doxorubicin - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Doxorubicin Market to Reach $1.7...
22157.jpg
Nivolumab Market Forecasts Indicate Robust Growth Driven by Advances in Cancer Immunotherapy and Increased Global Access to Care
15 févr. 2024 14h57 HE | Research and Markets
Dublin, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The "Nivolumab Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Recent advancements in cancer treatment and the...
22157.jpg
Global Hepatocellular Carcinoma Clinical Trials Review 2023: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
31 janv. 2024 06h58 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma - Global Clinical Trials Review, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial...
22157.jpg
MTG201 + Nivolumab Drug and Market Analysis 2023-2032: Sales Analytics, Clinical Assessment, SWOT Analysis, Emerging Competitors
30 janv. 2024 10h50 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MTG201 + nivolumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides...
22157.jpg
Regorafenib Drug and Market Analysis 2023-2032 with Forecasted Sales Data
30 janv. 2024 10h45 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Regorafenib Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers a comprehensive...
22157.jpg
Bile Duct Cancer Treatment Market Trends and Forecast 2031 - Market Set for Significant Growth by 2031 Amid Rising Incidences and Technological Advancements
09 janv. 2024 04h28 HE | Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Bile Duct Cancer Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
22157.jpg
Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032
14 déc. 2023 10h08 HE | Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...